Détention brevets de la classe C12N 15/45

Brevets de cette classe: 182

Historique des publications depuis 10 ans

5
4
8
8
7
10
7
21
20
13
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
The United States of America, as represented by the Secretary, Department of Health and Human Services
3014
5
Glaxosmithkline Biologicals S.A.
1602
4
Sichuan Clover Biopharmaceuticals, Inc.
54
4
Shenzhen Shenxin Biotechnology Co., Ltd.
49
4
Shenzhen Rhegen Biotechnology Co., Ltd.
53
4
Wuhan Rhegen Biotechnology Co., Ltd.
44
4
Boehringer Ingelheim Vetmedica GmbH
1274
3
Centre National de La Recherche Scientifique
11077
3
ID Pharma Co., Ltd.
42
3
The Research Foundation for Microbial Diseases of Osaka University
67
3
The University of Tokyo
4380
3
Beijing Cell-fusion Biotechnology Co., Ltd.
6
3
Shanghai King-cell Biotechnology Co. Ltd.
6
3
Guangzhou National Laboratory
66
3
Suzhou Juwei Biotech Co., Ltd
3
3
Children's Healthcare of Atlanta, Inc.
265
2
Cornell University
3444
2
Emory University
1722
2
Icahn School of Medicine at Mount Sinai
1048
2
Institute of Microbiology, Chinese Academy of Sciences
139
2
Autres propriétaires 120